Using radiation to delay changing treatment for breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether giving radiation to a few growing spots (1-3) can let you stay on your current drug longer, instead of switching to a new one right away. It's for people with metastatic breast cancer whose disease has been stable for months but now shows limited progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have metastatic breast cancer that has been confirmed by biopsy
- Your cancer has stayed under control for at least 12 months on your first treatment, or at least 6 months on your second or later treatment, then developed 1 to 3 new spots outside the brain
- You are willing to continue your current drug and get radiation to those growing spots
- You have not had triple-negative breast cancer (ER-, PR-, HER2-)
- You are able to fill out questionnaires and give blood samples for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a precise radiation treatment (SBRT) can target a few growing spots of estrogen receptor-positive breast cancer that has spread to other parts of the body. It also uses a special PET scan (FES PET/CT) to see how well the cancer responds. The goal is to slow down the cancer and delay the need for stronger treatments.
This trial tests whether adding a precise, high-dose radiation (called SABR) to your current targeted therapy can control a few growing spots of advanced breast cancer better than switching to a different drug. It is for people with ER-positive, HER2-negative breast cancer whose cancer has been well controlled for at least 6 months but now has 1–5 spots that are starting to grow.
This Phase 2 study tests whether adding a very focused type of radiation to standard drug treatment can better control metastatic breast cancer. It is for people whose cancer is only progressing in one spot, seen on a PET scan.
This trial tests whether treating each spot of cancer that has spread (but only a few spots) with focused radiation can help control breast cancer. It aims to see if this approach can stop the cancer from growing further without needing strong whole-body treatments right away.
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
This trial tests whether treating just the few spots where breast cancer has spread (called oligometastases) with radiation or surgery can help control the disease. It is for people whose cancer has spread to 3 or fewer places, each small in size, and who are healthy enough for local treatments.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.